Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
64.71B | 48.30B | 44.50B | 45.58B | 43.77B | 51.46B | Gross Profit |
8.21B | 4.64B | 4.57B | 5.63B | 4.96B | 5.66B | EBIT |
4.68B | 1.81B | 2.03B | 3.68B | 3.08B | 3.64B | EBITDA |
5.84B | 3.31B | 3.77B | 4.45B | 3.86B | 4.11B | Net Income Common Stockholders |
3.61B | 1.48B | 1.87B | 2.76B | 2.29B | 2.40B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.97B | 8.97B | 6.77B | 9.36B | 7.89B | 4.19B | Total Assets |
52.89B | 52.89B | 47.70B | 45.79B | 44.41B | 39.89B | Total Debt |
1.18B | 1.18B | 1.52B | 1.02B | 344.57M | 362.47M | Net Debt |
-7.50B | -7.27B | -4.63B | -7.69B | -6.88B | -3.57B | Total Liabilities |
15.55B | 15.55B | 13.34B | 12.42B | 12.78B | 11.92B | Stockholders Equity |
37.28B | 37.28B | 34.34B | 33.34B | 31.59B | 27.93B |
Cash Flow | Free Cash Flow | ||||
364.91M | 2.38B | -2.65B | 1.94B | 4.38B | -1.38B | Operating Cash Flow |
364.91M | 3.92B | -1.58B | 2.90B | 5.43B | -949.16M | Investing Cash Flow |
0.00 | -596.42M | -453.43M | -679.83M | -1.60B | -1.51B | Financing Cash Flow |
0.00 | -1.09B | -377.88M | -401.42M | -505.01M | -747.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥40.23B | 9.91 | 2.87% | 8.11% | 193.20% | ||
76 Outperform | $337.96B | 14.58 | 6.91% | 2.66% | 2.11% | 6.44% | |
74 Outperform | €386.98B | 12.10 | 8.09% | 3.16% | 11.62% | 19.32% | |
73 Outperform | €320.12B | 11.42 | 10.64% | 3.18% | 5.80% | 26.91% | |
64 Neutral | $4.36B | 12.05 | 5.23% | 249.94% | 4.13% | -10.23% | |
64 Neutral | ¥703.38B | 18.33 | 6.41% | 2.21% | 0.23% | 3.49% |